Compass Pathways Raises Undisclosed Amount After Trial Win

Deal Summary

Compass Pathways, a pioneer in psilocybin-based therapies, announced a new fundraising round following a successful clinical trial. The fast raise, with terms undisclosed, will support further development and potential commercialization of its treatments.